Arovella Therapeutics Limited

ASX:ALA Stock Report

Mkt Cap: AU$16.2m

Arovella Therapeutics Management

How experienced are the management team and are they aligned to shareholders interests?

2.5yrs

Average management tenure

CEO

Michael Baker

3yrs

Tenure

AU$604,351

Compensation

Dr. Michael Baker serves as Chief Executive Officer of Arovella Therapeutics Limited (formerly known as Suda Pharmaceuticals Ltd). since January 2, 2020 and served as its Executive Chairman until July 1, 2...

CEO Compensation Analysis

How has Michael Baker's remuneration changed compared to Arovella Therapeutics's earnings?
DateTotal Comp.SalaryCompany Earnings
Jun 30 2022AU$604kAU$303k

-AU$9m

Mar 31 2022n/an/a

-AU$8m

Dec 31 2021n/an/a

-AU$7m

Sep 30 2021n/an/a

-AU$6m

Jun 30 2021AU$403kAU$275k

-AU$5m

Mar 31 2021n/an/a

-AU$5m

Dec 31 2020n/an/a

AU$2m

Sep 30 2020n/an/a

-AU$1m

Jun 30 2020AU$385kAU$124k

-AU$4m

Compensation vs Market: Michael's total compensation ($USD419.19K) is above average for companies of similar size in the Australian market ($USD295.69K).

Compensation vs Earnings: Michael's compensation has increased whilst the company is unprofitable.

Leadership Team

NamePositionTenureCompensationOwnership
Michael Baker
CEO, MD & Director3yrsAU$604.35k0.57%
A$ 92.2k
Phillip Hains
Company Secretary & CFO2.5yrsno datano data
Nicole van der Weerden
Chief Operating Officerno datano datano data
Stephen Carter
Consultant3.33yrsAU$286.40kno data
Richard Franklin
Project Director & Member of Scientific Advisory Boardno datano datano data
Tony Macintyre
GM & CTO2yrsno datano data
Mini Bharathan
Senior Vice President of Development & Translational Medicineno datano datano data

2.5yrs

Average Tenure

Experienced Management: ALA's management team is considered experienced (2.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Michael Baker
CEO, MD & Director3yrsAU$604.35k0.57%
A$ 92.2k
Richard Franklin
Project Director & Member of Scientific Advisory Board4.67yrsno datano data
Gary Phillips
Independent Non-Executive Director0.50yrno datano data
Elizabeth Stoner
Independent Non-Executive Chairperson1.17yrsAU$63.28k0.039%
A$ 6.3k
Anil Sood
Member of Scientific Advisory Board1.83yrsno datano data
Stephen Watson
Member of Scientific Advisory Board4.33yrsno datano data
David Simmonds
Non-Executive Director3.83yrsAU$44.00k0.076%
A$ 12.3k
Debora Barton
Independent Non-Executive Director1.42yrsAU$72.01k0.039%
A$ 6.3k
Gunnar Birgegard
Member of Scientific Advisory Board1.75yrsno datano data
Reuben Benjamin
Member of Scientific Advisory Board1.42yrsno datano data
John Maher
Member of Scientific Advisory Board1.33yrsno datano data
Anastasios Karadimitris
Chairman of Scientific Advisory Boardno datano datano data

1.8yrs

Average Tenure

61yo

Average Age

Experienced Board: ALA's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.